Today's Reuters Health News Headlines - Yahoo! News:
|
|
U.S.-listed firms told to reveal Syria, Iran links: FT
Sun,11 Dec 2011 07:43 PM PST
Reuters -  NEW YORK (Reuters) - At least a dozen U.S.-listed companies have been told by the U.S. Securities and Exchange Commission to disclose business activity in and with Syria, Iran and others deemed "state sponsors" of terror by the state department, the Financial Times said on Sunday. The inquiries are part of SEC reviews of companies' investment risks to security holders. Sony Corp, Caterpillar Inc, American Express, Aecom Technology, Iridex and Veolia Environnement are among the companies that received letters from the SEC's corporate finance division, the report said. ...
Full Story | Top |
Olympus says preparing to file earnings by December 14
Sun,11 Dec 2011 06:42 PM PST
Reuters -  TOKYO (Reuters) - Olympus said on Monday it was preparing to file its July-September earnings by December 14, a necessary step for the disgraced 92-year-old firm to remain listed. The company also said it would hold a briefing on December 15 to explain the results after admitting to a $1.7 billion scheme to hide investment losses stretching back more than a decade. The scandal has put the future of the 92-year-old maker of cameras and endoscopes at risk. ...
Full Story | Top |
Ariad leukemia drug helps 47 percent of patient: study
Sun,11 Dec 2011 04:31 PM PST
Reuters - SAN DIEGO (Reuters) - Early results from a pivotal trial of Ariad Pharmaceuticals Inc's experimental leukemia drug ponatinib show it is effective in nearly half of patients who had stopped responding to currently available drugs. An interim look at the study, presented here at a meeting of the American Society of Hematology, shows that 47 percent of chronic myeloid leukemia (CML) patients with chronic-phase disease had a major response to ponatinib, meaning that at least two-thirds of their bone marrow was normal. ... Full Story | Top |
Analysis: U.S. focus on birth control may raise new concerns
Sun,11 Dec 2011 11:05 AM PST
Reuters -  WASHINGTON (Reuters) - A ruling last week on the morning-after pill, as well as government recommendations on new forms of birth control, could have long-lasting effects on women's perceptions of its safety, health experts say. Last Wednesday, the health secretary for the first time overruled government scientists, refusing to make the morning--after pill available to users of all ages without a prescription. ...
Full Story | Top |
Bayer CEO eyes falling margins in drugs, plastics
Sun,11 Dec 2011 11:01 AM PST
Reuters - FRANKFURT (Reuters) - Bayer expects to see falling profit margins in drugs and plastics as the euro debt crisis sends tremors through economy, chief executive Marijn Dekkers told a German newspaper. "There is an increasing trend towards cost-cutting on medicines, so the debt crisis is pressuring our margins," Dekkers told Tagesspiegel newspaper in a interview released ahead of publication on Monday. "Besides price pressure in HealthCare, demand is weakening for our plastics," he said. ... Full Story | Top |
Pharmacyclics' blood cancer drug responses rise
Sun,11 Dec 2011 08:04 AM PST
Reuters - SAN DIEGO (Reuters) - Interim results from an early stage trial of Pharmacyclics Inc's experimental blood cancer drug show the number of leukemia patients responding to the medicine has increased over time. At 10 months follow-up, 70 percent of patients treated with the lower dose of the drug, known as PCI-32756, had a significant improvement in their condition. That is up from the 48 percent response rate reported by trial investigators after six months of follow-up. ... Full Story | Top |
Gingrich fights off rivals in Iowa debate
Sat,10 Dec 2011 09:05 PM PST
Reuters -  DES MOINES, Iowa (Reuters) - Surging frontrunner Newt Gingrich fought off heavy attacks in a presidential debate in Iowa on Saturday from Republican rivals who portrayed him as a Washington insider and questioned his judgment. Gingrich, described by some critics as rash and petulant, kept his cool as his Republican rivals criticized him for making up to $1.6 million from housing giant Freddie Mac, for saying Palestinians were an "invented" people and for his troubled marital past. ...
Full Story | Top |
Romney's $10,000 bet falls flat in Iowa debate
Sat,10 Dec 2011 07:58 PM PST
Reuters -  DES MOINES (Reuters) - Republican presidential candidate Mitt Romney put his money where his mouth was on Saturday in a quip at a presidential debate that may have backfired. Romney, a multi-millionaire and a frontrunner for the Republican nomination, offered a $10,000 bet to opponent Texas Gov. Rick Perry in an argument over what Romney wrote about healthcare in his book "No Apologies." Former Massachusetts governor Romney tried to bet that he had not supported implementing an individual healthcare mandate, mistrusted by conservatives. "Rick, I'll tell you what: 10,000 bucks?," Romney said. ...
Full Story | Top |
Gene therapy proves effective for hemophilia B
Sat,10 Dec 2011 07:11 PM PST
Reuters - SAN DIEGO (Reuters) - A single treatment with gene therapy, an experimental technique for fixing faulty genes, has been shown to boost output of a vital blood clotting factor, possibly offering a long-term solution for people with hemophilia B. Researchers said the same technology was also being studied as a treatment for hemophilia A, the far more common type of the inherited bleeding disorder. "It is a technique for potentially permanently curing patients," said Dr. ... Full Story | Top |
Gene therapy proves effective for hemophilia B
Sat,10 Dec 2011 12:42 PM PST
Reuters - SAN DIEGO (Reuters) - A single treatment with gene therapy, an experimental technique for fixing faulty genes, has been shown for the first time to boost output of a vital blood clotting factor, possibly offering a long-term solution for people with hemophilia B. Researchers said the same technology was also being studied as a treatment for hemophilia A, the far more common type of the inherited bleeding disorder. "It is a technique for potentially permanently curing patients," said Dr. ... Full Story | Top |
Gingrich vs Romney rivalry in Iowa debate spotlight
Sat,10 Dec 2011 12:25 PM PST
Reuters -  DES MOINES, Iowa (Reuters) - The budding rivalry between surging Newt Gingrich and former frontrunner Mitt Romney will take center stage on Saturday in the first of two Republican presidential debates in Iowa over the next five days. Gingrich, Romney and four other White House contenders will make their case to voters in a race that polls show is still up for grabs less than a month before Iowa kicks off the state-by-state Republican nominating contest. The debate will be broadcast nationally on ABC at 9 p.m. EST from Drake University in Des Moines. ...
Full Story | Top |
Leukemia drug pulled from U.S. sparks new interest
Sat,10 Dec 2011 11:56 AM PST
Reuters - SAN DIEGO (Reuters) - A new study of leukemia drug Mylotarg, pulled from the U.S. market last year due to safety concerns, found it to be effective when used at low doses in older adults but questions about toxicity remain. Pfizer Inc voluntarily halted U.S. sales of Mylotarg, also known as gemtuzumab, after a study showed that adding it to chemotherapy did not extend survival for patients with previously untreated acute myeloid leukemia (AML), an aggressive bone marrow cancer. That trial also showed more deaths in the first couple of months of treatment. The fatality rate was 5. ... Full Story | Top |
Stem cells used to produce blood platelets
Sat,10 Dec 2011 11:35 AM PST
Reuters - SAN DIEGO (Reuters) - Scientists have for the first time created blood platelet cells by reprogramming stem cells derived from adult cells, offering the potential for a renewable supply of the fragile blood component. Researchers at the Center for iPS Cell Research and Application at Kyoto University in Japan presented data at a meeting of the American Society of Hematology showing they were able to create the cells in the laboratory and confirm they had the same life span as normal human platelets when infused in mice. ... Full Story | Top |
Olympus ousted CEO to visit Japan
Sat,10 Dec 2011 04:15 AM PST
Reuters -  TOKYO (Reuters) - Olympus Corp's ousted CEO, Michael Woodford, flies to Japan on Tuesday to press on with a battle to win back his job, as media reported that prosecutors plan to raid the homes of suspects in a $1.7 billion accounting fraud at the camera maker. Woodford wants to meet potential candidates for a new management team for which he will also seek shareholder and investor backing when the board comes up for election at an extraordinary shareholders' meeting, possibly in February. He will leave Japan on Friday morning, an assistant in Tokyo said in an e-mail. ...
Full Story | Top |
Hospital fire kills at least 84 in eastern India
Sat,10 Dec 2011 03:48 AM PST
Reuters -  KOLKATA, India (Reuters) - A fire tore through a seven-story private hospital in the eastern Indian city of Kolkata before dawn Friday, killing at least 84 people, most of them intensive care patients who were asleep and suffocated in the fumes. Thick smoke engulfed the crowded hospital and fire-fighters smashed windows to evacuate people down ladders and with sheets from upper floors. Other patients were wheeled out on trolleys. Rescue workers and locals criticised a lack of safety equipment and said staff fled the scene leaving windows and doors locked. ...
Full Story | Top |
| |
|
No comments:
Post a Comment